Checkmate Theraputics
Checkmate Therapeutics is a biotech company that discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology.
Checkmate Theraputics operates in biotechnology, oncology based in Asia-Pacific (APAC), founded in 2019.
Checkmate Theraputics is positioned in biotechnology, oncology, a segment that rewards a clear, focused offering.
Asia-Pacific (APAC) is where the company is located.
Directory data places it at the Series_A stage.
It has disclosed roughly $7.3B in funding.
| Sector | Biotechnology, Oncology |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2019 |
| Stage | series_a |
| Total funding | $7,300,000,000 |
Website: www.checkmatetx.com
Browse related
Sign in to view the contact information we hold for Checkmate Theraputics.
Create a free account
Create a free account